Registered Nurse in Oakland, MD Accepting Medicare

8 Registered Nurse nurses found. Showing 1 - 8

Michelle Wiltison, Registered Nurse - Diabetes Educator Medicare: Not Enrolled in Medicare Practice Location: 251 N 4th St, Oakland, MD 21550 Phone: 301-533-4271    Fax: 301-533-4673

Kathy Elaine Hay, RN Registered Nurse - Diabetes Educator Medicare: Not Enrolled in Medicare Practice Location: 251 N 4th St, Oakland, MD 21550 Phone: 301-533-4271

Elizabeth A Walter, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1025 Memorial Dr, Oakland, MD 21550 Phone: 301-334-7680    Fax: 301-334-7681

Linda L Welch, RN Registered Nurse - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1025 Memorial Dr, Oakland, MD 21550 Phone: 301-334-7680    Fax: 301-334-7681

Elsie Godwin, CRNA Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 251 N 4th St, Oakland, MD 21550 Phone: 301-533-4567

Eugenia Michele Artice, MSN, CRNP, FNP-C Registered Nurse - Oncology Medicare: Medicare Enrolled Practice Location: 251 N 4th St, Oakland, MD 21550 Phone: 301-533-4133    Fax: 301-533-4281

Kendra Lea Thayer, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 251 N 4th St, Oakland, MD 21550 Phone: 301-533-4295    Fax: 301-533-4328

Cynthia Lynn Hauser, RN NCM DN Registered Nurse - Case Management Medicare: Not Enrolled in Medicare Practice Location: 620 Sanders Ln, Oakland, MD 21550 Phone: 301-616-7814

News Archive

Houston professor uses stem cells to develop next-generation biologic pacemakers

University of Houston associate professor of pharmacology Bradley McConnell is helping usher in a new age of cardiac pacemakers by using stem cells found in fat, converting them to heart cells, and reprogramming those to act as biologic pacemaker cells.

Cosentyx (secukinumab) safe, effective for treating psoriasis patients

Novartis today announced new two-year results demonstrating sustained efficacy with Cosentyx (secukinumab) with an acceptable safety profile for the treatment of psoriasis patients. The data comes from the extension study of the pivotal Phase III FIXTURE and ERASURE trials.

Hearatlast to reduce operating costs significantly through restructuring

HearAtLast Holdings, Inc. (PINKSHEETS: HRAL), a leading provider of suitable affordable solutions to clients with hearing needs in the billion dollar hearing loss market, announced today that through the addition of Louis Isabella; CFO; and the Evans Martin group, the Company has identified several significant cost cutting measures.

Tax increases, Medicare cuts expected in Obama budget

President Obama will release his budget plan Monday, which is already getting its share of Republican detractors. In it, Obama will propose tax increases on the wealthy and $360 billion in cuts to Medicare and Medicaid, mostly in the form of payment cuts to providers and drug companies.

Read more Medical News

› Verified 3 days ago